MedTrace Logo

Radiomics-based Models for the Prediction of Pathological Response to Neoadjuvant Therapy in Gastric and Gastroesophageal Cancer

NCT06044961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-09-21

No results posted yet for this study

Summary

Identifying predictors of response to neoadjuvant therapy in gastric and gastro-oesophageal cancer early in the history of the disease would ensure optimal treatment planning.

The study aims to apply radiomics for the prediction of response to neoadjuvant therapy.

Conditions

  • Patients With Locally Advanced Carcinoma of the Stomach and Oesophagogastric Junction

Interventions

RADIATION

CT scan

All pre-operative CT scan collected

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-01
Primary Completion
2022-08-30
Completion
2022-11-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06044961 on ClinicalTrials.gov